Cathay International Holdings Limited (CTI.L) (CTI) Share Price, News & Analysis

Company Overview

Cathay International Holdings Limited, an investment holding company, invests and operates in the healthcare sector in the People's Republic of China. It operates through five segments: Lansen, Haizi, Natural Dailyhealth, Botai, and Hotel Operations. The Lansen segment manufactures, markets, and sells pharmaceuticals, cosmeceutical products, plant extracts, and healthcare products. This segment focuses on the rheumatic specialty prescription western pharmaceuticals for the treatment of autoimmune rheumatic diseases and dermatology indications; develops, manufactures, and distributes rheumatic drugs; and sells diagnostic kits and cosmeceutical products. The Haizi segment manufactures, markets, and sells inositol and phosphate related products. The Natural Dailyhealth segment provides plant extracts, such as bilberry, ginkgo extract, and ginseng extract for use as ingredients in health products. The Botai segment produces and sells collagen injectable fillers; and develops collagen related products. The Hotel Operations segment owns and operates The Crowne Plaza Hotel and Suites Landmark Shenzhen, a 5-star hotel located in the Lowu district of Shenzhen in the People's Republic of China. This segment's hotel consists of 312 rooms and suites, and banquet and meeting facilities. Cathay International Holdings Limited is based in Central, Hong Kong.

Key Stats

• Today's Range: N/A
• 50-Day Range: 0.75 to 0.75
• 52-Week Range: N/A
• Volume: 1,030 shs
• Average Volume: 151,589 shs
• Market Capitalization: £14.35 million
• P/E Ratio: 3.75
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CTI Stock Analysis - Frequently Asked Questions

How do I buy shares of Cathay International Holdings Limited (CTI.L)?

Shares of CTI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Cathay International Holdings Limited (CTI.L) own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cathay International Holdings Limited (CTI.L) investors own include AutoZone (AZO), Intel (INTC), TJX Companies (TJX), XPeng (XPEV), American Airlines Group (AAL), Abacus Health Products (ABAHF) and Acasti Pharma (ACST).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: N/A
• Industry: Drug Manufacturers - Major
• Sub-Industry: N/A
• Current Symbol: LON:CTI
• CIK: N/A
• Web: www.cathay-intl.com.hk
• Phone: +85228289289
• Fax: N/A
• Employees: 1,300
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 3.75
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 49.62
• Current Ratio: 1.64
• Quick Ratio: 1.46

Sales & Book Value

• Annual Sales: £76.68 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 0.09
• Book Value: GBX 7.70 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,913,810,048
• Free Float: N/A
• Market Cap: £14.35 million
• Optionable: Not Optionable
• Beta: N/A